# OnCo record paper-shelley-hwang-j-clin-oncol-2021 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-shelley-hwang-j-clin-oncol-2021/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-shelley-hwang-j-clin-oncol-2021" ;
  schema:name "Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline"@en ;
  schema:description "Paper by E. Shelley Hwang indexed on Europe PMC as PubMed record 33507815, in Journal of Clinical Oncology (2021), one of the most cited records naming an author with this name at Duke Cancer Institute."@en ;
  schema:url <https://onco.cc/key-papers/paper-shelley-hwang-j-clin-oncol-2021/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1200/jco.20.03399>, <https://pubmed.ncbi.nlm.nih.gov/33507815/>, <https://europepmc.org/article/MED/33507815> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1200/jco.20.03399> ;
  schema:datePublished "2021"^^xsd:gYear ;
  schema:author "Korde LA, Somerfield MR, Carey LA, et al." ;
  onco:people <https://onco.cc/people/shelley-hwang/> ;
  onco:journals <https://onco.cc/journals/jco/> .